Objective
A major issue in cost effectiveness analysis is that of the value to place on a quality adjusted life year (QALY), commonly used as a measure of health effectiveness across Europe. This has come to the fore in several European countries, resulting from the creation of national health technology and pharmaceutical assessment agencies. Such agencies were established to make recommendations on technology adoption, addressing issues of affordability and sustainability of publicly funded health care systems. Recommendations are most often made on the basis of QALYs produced relative to costs incurred. Methods of estimating cost per QALY, based on rigorous decision analytic models, are now very sophisticated. However, 'threshold' values adopted (such as £20-40,000 per QALY above or below which a new therapy will be rejected or recommended for adoption in England) are essentially arbitrary, with little or no economic foundation.
This critical policy issue is reflected in growing interest across Europe in development of more sound methods to elicit such a value. The aim of this project would, therefore, be to develop robust methods to determine the monetary value of a QALY across a number of European Member States. This would be addressed in two ways: through 'modelling' such a value based on values of statistical lives currently used (or implicit values from adoption decisions in various fields) across Member States; and through survey research to test two methods of deriving a societal willingness-to-pay (WTP) based monetary value of a QALY. A European-level research initiative is required in the interests of subsidiarity and coherence. Different Member States will have different levels of affordability of QALY production. Country-specific values would lead to improve decision- making and efficiency. But it is crucial that WTP-based values generated have been rigorously tested across cultures using a consistent methodological approach.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2005-SSP-5-A
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
NEWCASTLE UPON TYNE
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.